Jeffrey Tate, Chief Operating Officer at Cyclo Therapeutics, Inc. (CYTH), bought 29,941 shares at $0.71 ($21K) on 2023-04-20, disclosed to the SEC on 2023-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CYTH | BUY | 2021-03-30 | $15K | — | Filing → |